Insight Guru Inc.

09/25/2026 | Press release | Distributed by Public on 09/25/2026 01:29

13 Large Cap Stocks Hit 52-Week Highs On Thursday

A new high list shows a heavy concentration in one corner of the market, raising questions about valuation.

By industry, the list is led by Life Sciences Tools & Services with 6 names. As of Thursday, September 24, there are 13 Large Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. Meta Platforms (META) is the largest company on the list, with a market value of about $1977.4 billion; its stock has gained 36.5% over the last month.

For context, the S&P 500 has returned +0.5% over the last month. With some names on the list showing gains far beyond that, the question is what kind of business performance is supporting these prices.

The Biggest Names On The List

The table below shows the 10 largest of the 13 names, sorted by market capitalization, with returns over four windows:

Tickers Market
Cap
1D
% Chg
1W
% Chg
1M
% Chg
1Y
% Chg
META $1,977.41 Bil 4.5% 14.1% 36.5% 3.3%
AMD $1,026.95 Bil 2.4% 15.4% 31.3% 291.1%
TMO $251.68 Bil 2.0% 3.0% 8.1% 44.9%
NET $127.14 Bil 1.8% 7.5% 29.3% 60.7%
HPE $84.8 Bil 1.9% 4.1% 19.2% 161.8%
MRNA $77.54 Bil 7.0% 23.2% 22.7% 655.4%
WBD $77.44 Bil 0.3% 9.2% 6.7% 57.7%
NTRA $58.57 Bil 4.6% 11.6% 21.4% 136.5%
A $48.74 Bil 4.5% 10.6% 11.7% 38.3%
TWLO $45.78 Bil 3.1% 21.7% 33.8% 189.7%

This screen covers US and Canada-listed stocks in the Trefis coverage universe. Large Cap here means a market value above $40 billion.

Are the valuations keeping up with the price runs?

Advanced Micro Devices (AMD) has seen its stock gain 31.3% over the last month. The company trades at 159.6 times trailing earnings, and its revenue grew 39.5% over the last twelve months, and its operating margin was 15.7%.

Meta Platforms (META) also had a strong month, with its stock up 36.5%. It trades at 29.0 times trailing earnings, while its revenue grew 27.7% over the last twelve months, and its operating margin was 38.1%.

Is a 52-week high a buy signal?

A stock at its highest price of the past year is a sign of strength, and that strength can persist. But a price is not a verdict on the business itself.

The disciplined next step is to look past the price chart. An investor should ask whether the company's growth and profitability can justify its new, higher valuation.

A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.

One more pattern worth noticing: 7 of the 13 names are Health Care stocks. When a whole group is making new highs together, a health care ETF like XLV, which holds 5 of these names, is one way to own part of the group's strength without betting on which single name leads it from here.

New Highs Fade. Discipline Compounds

Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.

That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Use the high list for ideas; use the portfolio for the compounding.

Insight Guru Inc. published this content on September 25, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 25, 2026 at 07:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]